Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfred Yung

Showing results (111-120 of 217) with videos related to

Pageof 22
Sort By:
Journal of Neuro-Oncology|April 28, 2006
Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant statusMorris D Groves, Vinay K Puduvalli, Charles A Conrad, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Aggregation of cancer in first-degree relatives of patients with gliomaMichael E Scheurer, Carol J Etzel, Mei Liu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 27, 2006
A novel CRM1-dependent nuclear export signal in adenoviral E1A protein regulated by phosphorylationHong Jiang, Melissa V Olson, Diana R Medrano, et al.
Clinical & Experimental Metastasis|July 13, 2001
Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactionsN Chandrasekar, S Jasti, W K Alfred-Yung, et al.
Cancer|May 2, 2013
Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastomaShlomit Yust-Katz, Diane Liu, Ying Yuan, et al.
Oncogene|April 8, 2025
Retraction Note: Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTENDimpy Koul, Ranjani Parthasarathy, Ruijun Shen, et al.
Neuro-Oncology|March 8, 2011
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03Fabio M Iwamoto, Kathleen R Lamborn, John G Kuhn, et al.
Cancer Research|May 8, 2007
Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumorsMelissa V Olson, David G Johnson, Hong Jiang, et al.
Neoplasia (New York, N.Y.)|October 7, 2005
Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenovirusesHong Jiang, Ramon Alemany, Candelaria Gomez-Manzano, et al.
Cancer Research|March 9, 2005
Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastomaJanice M Nigro, Anjan Misra, Li Zhang, et al.
Pageof 22

Showing results (111-120 of 217) with videos related to

Sort By:
Pageof 22
Journal of Neuro-Oncology|April 28, 2006
Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant statusMorris D Groves, Vinay K Puduvalli, Charles A Conrad, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2007
Aggregation of cancer in first-degree relatives of patients with gliomaMichael E Scheurer, Carol J Etzel, Mei Liu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 27, 2006
A novel CRM1-dependent nuclear export signal in adenoviral E1A protein regulated by phosphorylationHong Jiang, Melissa V Olson, Diana R Medrano, et al.
Clinical & Experimental Metastasis|July 13, 2001
Modulation of endothelial cell morphogenesis in vitro by MMP-9 during glial-endothelial cell interactionsN Chandrasekar, S Jasti, W K Alfred-Yung, et al.
Cancer|May 2, 2013
Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastomaShlomit Yust-Katz, Diane Liu, Ying Yuan, et al.
Oncogene|April 8, 2025
Retraction Note: Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTENDimpy Koul, Ranjani Parthasarathy, Ruijun Shen, et al.
Neuro-Oncology|March 8, 2011
A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03Fabio M Iwamoto, Kathleen R Lamborn, John G Kuhn, et al.
Cancer Research|May 8, 2007
Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumorsMelissa V Olson, David G Johnson, Hong Jiang, et al.
Neoplasia (New York, N.Y.)|October 7, 2005
Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenovirusesHong Jiang, Ramon Alemany, Candelaria Gomez-Manzano, et al.
Cancer Research|March 9, 2005
Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastomaJanice M Nigro, Anjan Misra, Li Zhang, et al.
Pageof 22